Important note

This AI stock analysis for Walgreens is not up to date. Creating and accessing our AI stock Analysis (powered by our data and Chat GPT) is only available for our premium users. Sign up to get access today!

Walgreens - AI Stock Analysis

Analysis generated April 2, 2024

Walgreens, known formally as Walgreens Boots Alliance, Inc., is a leading pharmacy retailer and wholesaler with a strong international presence. The company operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. Walgreens provides pharmacy, health and wellness services as well as personal care, beauty products, and convenience goods. The group has a rich history and holds a significant position in the market as it caters to a large and diversified customer base.

Fundamental Analysis

In the most recent quarter, Walgreens reported a revenue of $36.9 billion, which not only grew by 0.45% from the preceding quarter but also indicated a notable year-on-year growth of 6.31%. This steady growth trajectory is indicative of the company's robust business model and resilient demand for its offerings, notwithstanding cyclical economic dynamics.

However, a stark contrast is observed in the net income for the last quarter, which drastically fell to $5.91 billion. This translates to a staggering decrease of 8,717.91% compared to the prior quarter and a year-over-year decline of 940.40%. Such a decline prompts a concern about the company's profitability and transient headwinds affecting the bottom line.

Similarly, EBITDA for the last quarter experienced an alarming contraction of 1,325.61% quarter-on-quarter and 539.82% when compared with the same period last year. These figures demonstrate significant underperformance in operational effectiveness and raise questions about sustainability in the current operating environment.

Walgreens is currently trading at a forward P/E ratio of 30.17. This elevated P/E ratio may suggest that the stock is overvalued, potentially reflecting investor skepticism about future earnings growth, or it could imply a premium for perceived quality and stability within the pharmacy retail sector.

Technical Analysis

The stock is currently in a bearish trend with the SMA10 (Simple Moving Average over 10 periods) standing at 20.66, which is lower than the previous reading of 20.89. This indicates a potential ongoing decline in the share price.

The Relative Strength Index (RSI) stands at 50.4, signifying a neutral technical posture. This suggests indecision in the market, where neither bulls nor bears have firm control, and thus, merits cautious observation for either a breakout or breakdown from this equilibrium.

Alternative Data Analysis

Walgreens has seen a 28% decrease in job postings, a sign that may suggest cost-cutting efforts and a cautious approach towards future hiring.

Customer acquisition data is mixed, yet leans positive. With a 10% uptick in web traffic to 70 million visitors, this trend suggests an expanding customer base and higher potential sales. Although the mobile application downloads remained stagnant, consistent new user acquisition implies steady consumer interest in digital engagement.

Customer engagement presents a varied narrative. Instagram followers remain steady at 370,000, while Twitter has noted a slight drop-off of 1% in its followers count, which stands at 810,000. These metrics point to a stable but unremarkable growth in social media engagement, worth monitoring for changes that may hint at public sentiment shifts.

Conclusion and Recommendation

Based on the comprehensive analysis, Walgreens exhibits mixed signals across fundamental, technical, and alternative data spectrums. The year-on-year revenue growth is promising, however, the substantial decline in profitability, concerning EBITDA figures, and a high P/E ratio indicate underlying challenges and a potential overestimation of value. The technical indicators lean towards a bearish sentiment, although the neutral RSI suggests consolidation at current levels may be in play. The alternative data analysis portrays a company that is prudent in hiring, possibly due to cost structure optimization, while customer engagement and acquisition present a cautiously optimistic picture.

For investors, these findings suggest a recommendation to hold on the purchase or sale of Walgreens stock until a clearer direction in company performance and market sentiment is established. Observing subsequent quarterly results, technical pattern resolution, and engagement trends could provide additional insights for a more informed investment decision in the future.